Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome

NCT01838551 is registered in ClinicalTrials.gov with Cortendo AB as lead sponsor.

NCT NCT01838551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01838551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Lead sponsor
Cortendo AB
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2014
Completion date
November 30, 2018
Enrollment
94 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

endogenous cushing's syndrome